RELATIONSHIP BETWEEN LIPOPHILICITY AND HEPATIC DISPERSION AND DISTRIBUTION FOR A HOMOLOGOUS SERIES OF BARBITURATES IN THE ISOLATED-PERFUSED IN-SITU RAT-LIVER

被引:0
|
作者
CHOU, CH
EVANS, AM
FORNASINI, G
ROWLAND, M
机构
[1] UNIV MANCHESTER, DEPT PHARM, MANCHESTER M13 9PL, LANCS, ENGLAND
[2] UNIV S AUSTRALIA, SCH PHARM, ADELAIDE, AUSTRALIA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hepatic disposition kinetics of a homologous series of 5-n-alkyl-5-ethyl barbituric acids (methyl, ethyl, propyl, butyl, and pentyl) were determined using a single-pass perfused in situ rat liver preparation. The perfusion experiments were conducted using protein-free Krebs bicarbonate medium, delivered at a constant flow of 15 ml/min. Each barbiturate was injected separately into the portal vein as a rapid bolus (25 mug/50 mul) at appropriate intervals in a random order. The venous outflow concentrations of the barbiturates were determined by HPLC. A nonlinear least squares program was used to fit the axial dispersion model of hepatic elimination to the outflow profiles. With increasing length of the alkyl chain, there was a significant increase in the volume of distribution in the liver (0.85 +/- 0.12 ml/g for methyl and 487 +/- 1.27 ml/g for pentyl), which led to an increased organ mean transit time (35 +/- 2.4 sec for methyl and 223 +/- 32.8 sec for pentyl). The increased volume of distribution may have arisen from greater binding to intracellular proteins and/or greater partitioning into lipophilic components of hepatic tissue. The dispersion numbers of this homologous series, a measurement of relative axial spreading, were similar (0.28-0.39), despite the wide range of log P values (0.02-2.23) among them. The similarity between the dispersion number for each barbiturate and that for reference markers (erythrocytes, albumin, and water) suggests that the relative axial spreading of these barbiturates is determined primarily by the heterogeneity of the hepatic vasculatory system.
引用
收藏
页码:933 / 938
页数:6
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF SOME HOMOLOGOUS SERIES OF BARBITURATES IN INTACT RAT AND IN ISOLATED PERFUSED RAT-LIVER
    YIH, TD
    VANROSSUM, JM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1977, 203 (01): : 184 - 192
  • [2] THE EFFECTS OF HYPERPERFUSION IN THE ISOLATED-PERFUSED RAT-LIVER
    NAKAGAWA, T
    WEISIGER, RA
    EMOND, JC
    GASTROENTEROLOGY, 1995, 108 (04) : A1128 - A1128
  • [3] STEVIOSIDE IS NOT METABOLIZED IN THE ISOLATED-PERFUSED RAT-LIVER
    ISHIIIWAMOTO, EL
    BRACHT, A
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1995, 87 (02) : 167 - 175
  • [4] THE DISPOSITION OF MORPHINE AND ITS METABOLITES IN THE IN-SITU RAT ISOLATED-PERFUSED LIVER
    EVANS, AM
    SHANAHAN, K
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (04) : 333 - 339
  • [5] DISPOSITION OF CIPROFLOXACIN IN THE ISOLATED-PERFUSED RAT-LIVER
    ABADIA, AR
    DEFRANCESCO, L
    GUAITANI, A
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (02) : 197 - 200
  • [6] METABOLISM OF CAFFEIC ACID IN THE ISOLATED-PERFUSED RAT-LIVER
    GUMBINGER, HG
    VAHLENSIECK, U
    WINTERHOFF, H
    PLANTA MEDICA, 1993, 59 (06) : 491 - 493
  • [7] METABOLIC FUNCTION OF THE ISOLATED-PERFUSED RAT-LIVER IN CHRONIC SEPSIS
    DAHN, MS
    LANGE, MP
    MCCURDY, B
    MAHAFFEY, S
    JOURNAL OF SURGICAL RESEARCH, 1995, 59 (02) : 287 - 291
  • [8] REACTIVE OXYGEN INDUCING VASOCONSTRICTION IN THE ISOLATED-PERFUSED RAT-LIVER
    IKAI, I
    CHANCE, B
    KUMAR, C
    FREE RADICAL BIOLOGY AND MEDICINE, 1994, 16 (05) : 539 - 545
  • [9] FLOW DEPENDENCE OF METOPROLOL ELIMINATION IN ISOLATED-PERFUSED RAT-LIVER
    SHEN, GS
    ZHANG, YD
    LI, MY
    SHEN, JP
    ACTA PHARMACOLOGICA SINICA, 1994, 15 (05): : 430 - 432
  • [10] THE INFLUENCE OF PERFUSATE HEMATOCRIT UPON HEPATIC OXYGEN-UPTAKE IN THE ISOLATED-PERFUSED RAT-LIVER
    ALEXANDER, B
    ASLAM, M
    BENJAMIN, IS
    JOURNAL OF PHYSIOLOGY-LONDON, 1994, 475P : P72 - P73